Mark A Vanden Avond (Mark Vanden Avond)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Duchenne Muscular Dystrophy

Subarachnoid Hemorrhage

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca A Slick, Jessica Sutton, Margaret Haberman, Benjamin S O'Brien, Jennifer A Tinklenberg, Aashay Mardikar, Mariah J Prom, Margaret Beatka, Melanie Gartz, Mark A Vanden Avond, Emily Siebers, David L Mack, J Patrick Gonzalez, Allison D Ebert, Kanneboyina Nagaraju, Michael W Lawlor
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy. Biology open (2024)
David C Jewett, Donisha S N K Liyanagamage, Mark A Vanden Avond, Molly A B Anderson, Kyleigh A Twaroski, Morgan A Marek, Kimberly F James, Tapasya Pal, Anica Klockars, Pawel K Olszewski, Allen S Levine
Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats. Nutrients 14 (5) (2022)